Abstract |
Chemo-resistance to conventional therapy is a major barrier requiring further investigation in hepatocellular carcinoma (HCC). Cancer stem like cells (CSCs) contribute to the tumorigenicity, progression, and chemo-resistance of malignancies. Studies have implicated the anti- cancer effects of arsenic trioxide (ATO) and have explored the underlying mechanisms. However, whether ATO might reverse chemo-resistance by inhibiting the CSC like properties remains under investigation. Here, we explored the potential of ATO in chemotherapy in constructed multiple drug resistant (MDR) liver cancer cells. ATO re-sensitized the MDR Bel-7402 cells (BelMDR) cells to chemotherapeutic drugs, an effect mediated by the inhibition of NF-κB pathway and CSCs properties. For the molecular mechanisms, via inducing the DNA de-methylation, ATO activated the microRNA-148a (miR-148a), leading to the repression of NF-κB pathway by targeting the 3'-UTR of p65. In summary, epigenetic regulation of miR-148a by ATO is an important mechanism in drug resistance that decreases the expression of NF-κB and hence represses CSC like phenotype. These findings may suggest a novel mechanism for HCC treatment.
|
Authors | Yuting Wang, Fei Jiang, Kailin Jiao, Liang Ju, Qinqiang Liu, Yuan Li, Lin Miao, Zhong Li |
Journal | Experimental cell research
(Exp Cell Res)
Vol. 386
Issue 2
Pg. 111739
(01 15 2020)
ISSN: 1090-2422 [Electronic] United States |
PMID | 31759055
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
- 3' Untranslated Regions
- Antineoplastic Agents
- MIRN148 microRNA, human
- MicroRNAs
- Transcription Factor RelA
- Oxaliplatin
- Arsenic Trioxide
- Fluorouracil
|
Topics |
- 3' Untranslated Regions
- Antineoplastic Agents
(pharmacology)
- Arsenic Trioxide
(pharmacology)
- Cell Line, Tumor
- DNA Methylation
(drug effects)
- Drug Resistance, Neoplasm
(drug effects, genetics)
- Epigenesis, Genetic
- Fluorouracil
(pharmacology)
- Gene Expression Regulation, Neoplastic
- Hepatocytes
(drug effects, metabolism, pathology)
- Humans
- MicroRNAs
(genetics, metabolism)
- Neoplastic Stem Cells
- Oxaliplatin
(pharmacology)
- Signal Transduction
- Transcription Factor RelA
(genetics, metabolism)
|